Literature DB >> 27557679

Late infectious endocarditis of surgical patch closure of atrial septal defects diagnosed by 18F-fluorodeoxyglucose gated cardiac computed tomography (18F-FDG-PET/CT): a case report.

Estelle Honnorat1,2, Piseth Seng3,4, Alberto Riberi5, Gilbert Habib6, Andreas Stein1,2.   

Abstract

BACKGROUND: In contrast to percutaneous atrial septal occluder device, surgical patch closure of atrial defects was known to be no infective endocarditis risk. CASE
PRESENTATION: We herein report the first case of late endocarditis of surgical patch closure of atrial septal defects occurred at 47-year after surgery. On September 2014, a 56-year-old immunocompetent French Caucasian man was admitted into the Emergency Department for 3-week history of headache, acute decrease of psychomotor performance and fever at 40 °C. The diagnosis has been evoked during his admission for the management of a brain abscess and confirmed using 18F-fluorodeoxyglucose gated cardiac computed tomography (18F-FDG-PET/CT). Bacterial cultures of surgical deep samples of brain abscess were positive for Streptococcus intermedius and Aggregatibacter aphrophilus as identified by the matrix-assisted laser desorption/ionization-time of flight (MALDI-TOF) mass spectrometry and confirmed with 16S rRNA gene sequencing. The patient was treated by antibiotics for 8 weeks and surgical patch closure removal.
CONCLUSIONS: In summary, late endocarditis on surgical patch and on percutaneous atrial septal occluder device of atrial septal defects is rare. Cardiac imaging by the 18F-fluorodeoxyglucose gated cardiac computed tomography (18F-FDG-PET/CT) could improve the diagnosis and care endocarditis on surgical patch closure of atrial septal defects while transthoracic and transesophageal echocardiography remained difficult to interpret.

Entities:  

Keywords:  18F-FDG-PET/CT; Aggregatibacter aphrophilus; Atrial septal defects; Bacteria; Brain abscess; Diagnosis; Human; Infection; Infective endocarditis; PET scan; Streptococcus intermedius; Surgical patch closure; Treatment

Mesh:

Substances:

Year:  2016        PMID: 27557679      PMCID: PMC4995769          DOI: 10.1186/s13104-016-2223-z

Source DB:  PubMed          Journal:  BMC Res Notes        ISSN: 1756-0500


Background

Infectious complication of atrial septal occlude device is rare that represented about 0.1 % of cases [1]. We herein report the first case of endocarditis at 47-year after surgical closure of atrial septal defects discovered by positron emission tomography with 18F-fluorodeoxyglucose gated cardiac computed tomography (18F-FDG-PET/CT).

Case presentation

On September 2014, a 56-year-old immunocompetent French Caucasian man was admitted into the Emergency Department for 3-week history of headache, acute decrease of psychomotor performance and fever at 40 °C. In his medical past-history, he underwent a surgical patch closure of atrial septal defects for patent foramen ovale at 9 years old and dental care at 5 months before his admission. Laboratory investigations revealed an elevated leukocyte count at 12.6 × 109/L with an elevated neutrophil count at 8.4 × 109/L, a normal platelet count at 180 × 109/L, an elevated C reactive protein rate at 97 mg/L and negative blood culture. A brain magnetic resonance imaging (MRI) revealed a right occipital cerebral abscess (27 × 36 × 43 mm, hyper intense T2) (Fig. 1).
Fig. 1

A brain magnetic resonance imaging (MRI) showing a unique brain abscess (27 × 36 × 43 mm)

A brain magnetic resonance imaging (MRI) showing a unique brain abscess (27 × 36 × 43 mm) He underwent surgical brain abscess drainage. Bacterial cultures of surgical deep samples of brain abscess were positive for Streptococcus intermedius and Aggregatibacter aphrophilus as identified by the matrix-assisted laser desorption/ionization-time of flight (MALDI-TOF) mass spectrometry and confirmed with molecular identification (16 s gene sequencing). The patient was treated first with an empiric antibiotherapy with cefotaxim 4 g every 8 h associated with metronidazole 500 mg every 8 h and cotrimoxazole 800/160 mg every 8 h. One week later, the antibiotic treatment was modified for ceftriaxone 2 g/day associated with metronidazole 500 mg every 8 h and rifampicin 300 mg every 8 h. A transthoracic echocardiographic examination and a body scan revealed no abnormality. A transesophageal echocardiography showed a high right left shunt suggestive of atrial septal patch dehiscence without direct sign of. An 18F-FDG-PET/CT showed an intense linear hypermetabolism opposite the interauricular septum compatible with an endocarditis on the intracardiac device (Fig. 2). Transesophageal echocardiography after 6 weeks of antibiotic treatment showed a filamentous image opposite the mitral valve and no vegetation image was found. A second 18F-FDG-PET/CT kept showing hypermetabolism on the surgical patch closure of atrial septal defects. The patient was treated by antibiotics for 8 weeks.
Fig. 2

The 18F-fluorodeoxyglucose gated cardiac computed tomography (18F-FDG-PET/CT) imaging showing hypermetabolism hyperactivity around the interauricular septum

The 18F-fluorodeoxyglucose gated cardiac computed tomography (18F-FDG-PET/CT) imaging showing hypermetabolism hyperactivity around the interauricular septum At the end of antibiotic treatment transthoracic echocardiographic examination showed an exclusive right left shunt, confirming dehiscence of the surgical patch closure of atrial septal defects. Surgical removal of surgical patch closure of atrial septal defects was necessary on April 2015 with replacement by a bovine pericardial patch. No antibiotics were given during explantation. Explanted atrial surgical patch closure of atrial septal defects looked swollen and calcified with negative bacterial cultures. The patient recovered without further complication. His hemiparesis fully disappeared; he only kept discrete amnesic and attentional failures. He presents a sequelae of attentional and memory deficits at 1 year of follow-up.

Discussion

In contrast to percutaneous atrial septal occluder device, surgical patch closure of atrial septal defects was known to be associated with no infective endocarditis risk [2]. To our best knowledge, only one case of endocarditis on surgical patch of ventricular septal defect [3] and 17 cases of bacterial endocarditis on percutaneous atrial septal occluder device [4-15] have been reported. In our case, the late onset of the infection occurred at 47-year after surgery, and it suggests that origin of endocarditis of surgical patch closure of atrial septal defects was a hematogenous spread of bacteria during the dental care at 5 months before. Diagnosis of endocarditis on atrial septal occluder device is generally done by transthoracic echocardiographic or transesophageal echocardiography. Therefore, in our case the diagnosis has been evoked during his admission for the management of a brain abscess, and established using 18F-FDG-PET/CT while transthoracic and transesophageal echocardiography remained difficult to interpret. The benefit of 18F-FDG-PET/CT has been demonstrated in the diagnosis of prosthetic valve endocarditis cardiac device-related endocarditis for detect infection by highlighting inflammatory leukocytes express a high density of glucose transporters and are highly metabolically active with the high spatial resolution of cardiac tomography and angiography, and it was recently added to the diagnosis of infective endocarditis criteria [16, 17].

Conclusion

In summary, late endocarditis on surgical patch and on percutaneous atrial septal occluder device of atrial septal defects is rare. We believe that the contribution of 18F-FDG-PET/CT could improve the diagnosis and care of endocarditis on surgical patch closure or percutaneous atrial septal occluder device of atrial septal defects. A prolonged antibiotherapy and surgical management with surgical patch removal is a major therapeutic option of endocarditis on surgical patch closure of atrial septal defects.
  17 in total

1.  Infective endocarditis resulting from CardioSEAL closure of a patent foramen ovale.

Authors:  Jeffrey A Goldstein; Michael A Beardslee; Haodong Xu; Thoralf M Sundt; John M Lasala
Journal:  Catheter Cardiovasc Interv       Date:  2002-02       Impact factor: 2.692

2.  Improving the Diagnosis of Infective Endocarditis in Prosthetic Valves and Intracardiac Devices With 18F-Fluordeoxyglucose Positron Emission Tomography/Computed Tomography Angiography: Initial Results at an Infective Endocarditis Referral Center.

Authors:  María N Pizzi; Albert Roque; Nuria Fernández-Hidalgo; Hug Cuéllar-Calabria; Ignacio Ferreira-González; María T Gonzàlez-Alujas; Gerard Oristrell; Laura Gracia-Sánchez; Juan J González; José Rodríguez-Palomares; Manuel Galiñanes; Olga Maisterra-Santos; David Garcia-Dorado; Joan Castell-Conesa; Benito Almirante; Santiago Aguadé-Bruix; Pilar Tornos
Journal:  Circulation       Date:  2015-08-14       Impact factor: 29.690

3.  Infective endocarditis following implantation of amplatzer atrial septal occluder.

Authors:  Ram Prakash Balasundaram; S Anandaraja; Rajnish Juneja; Shiv Kumar Choudhary
Journal:  Indian Heart J       Date:  2005 Mar-Apr

4.  Images in cardiovascular medicine. Incomplete endothelialization and late development of acute bacterial endocarditis after implantation of an Amplatzer septal occluder device.

Authors:  Timothy C Slesnick; Alan W Nugent; Charles D Fraser; Bryan C Cannon
Journal:  Circulation       Date:  2008-05-06       Impact factor: 29.690

5.  Meta-analysis of transcatheter closure versus medical therapy for patent foramen ovale in prevention of recurrent neurological events after presumed paradoxical embolism.

Authors:  Shikhar Agarwal; Navkaranbir Singh Bajaj; Dharam J Kumbhani; E Murat Tuzcu; Samir R Kapadia
Journal:  JACC Cardiovasc Interv       Date:  2012-07       Impact factor: 11.195

6.  Late infective endocarditis of an atrial septal occluder device presenting as a cystic mass.

Authors:  Jeroen Walpot; Bram Amsel; Inez Rodrigus; W Hans Pasteuning; Jan Koeman; Raymond Hokken
Journal:  Echocardiography       Date:  2011-07-01       Impact factor: 1.724

7.  Reoperation for prosthetic ventricular septal defect patch endocarditis: long-term results with an autologous atrial septal patch.

Authors:  Takako Miyazaki; Masaaki Yamagishi; Hitoshi Yaku
Journal:  Gen Thorac Cardiovasc Surg       Date:  2011-11-15

8.  Endocarditis after closure of ventricular septal defect by transcatheter device.

Authors:  Oded Scheuerman; Elchanan Bruckheimer; Nufar Marcus; Vered Hoffer; Ben-Zion Garty
Journal:  Pediatrics       Date:  2006-05-01       Impact factor: 7.124

9.  Surgical patch closure of atrial septal defects.

Authors:  Richard A Hopkins; Arthur A Bert; Bryan Buchholz; Kathleen Guarino; Merry Meyers
Journal:  Ann Thorac Surg       Date:  2004-06       Impact factor: 4.330

10.  Late bacterial endocarditis of an amplatzer atrial septal defect occluder device.

Authors:  Firas Zahr; William E Katz; Yoshiya Toyoda; William D Anderson
Journal:  Am J Cardiol       Date:  2010-01-15       Impact factor: 2.778

View more
  2 in total

1.  Complications of trans-catheter closure of atrial septal defects.

Authors:  Deepak Narayanan; Ben Babu Kurien; Santhosh Regini Benjamin; Korah Thomas Kuruvila; Madhu Andrew Philip; Roy Thankachen; Oomen Kattunilam George
Journal:  Indian J Thorac Cardiovasc Surg       Date:  2022-03-21

2.  A Rare Case of Non-Prosthetic Aortic Valve Infectious Endocarditis Caused by Achromobacter xylosoxidans.

Authors:  Ricardo Lessa de Castro; Neiberg de Alcantara Lima; Danielli Oliveira da Costa Lino; Thomas Austin Melgar
Journal:  Am J Case Rep       Date:  2020-07-21
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.